Form 13-F position report

LEGEND BIOTECH CORP

Reported by Boxer Capital LLC

LEGN CUSIP 52490G102 Manager CIK 0001465837

Reported 600,000 shares, unchanged from the prior quarter.

Reported value -2.7%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 2.15% This manager · Q3 2023
Shares 600,000 Quarter-end amount reported
Reported value $40,302,000 Fair value at quarter end
Consecutive quarters held 2 Through Q3 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-06-30 41418000
2023-09-30 40302000
2023-12-31 36102000
2024-03-31 33654000
2024-06-30 26574000
2024-09-30 29238000
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for LEGEND BIOTECH CORP held by Boxer Capital LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -600,000 (-100.0%) 0 $0 2025-02-14
Q3 2024 Unchanged 600,000 0 (0.0%) 1.43% $29,238,000 2024-11-14
Q2 2024 Unchanged 600,000 0 (0.0%) 1.4% $26,574,000 2024-08-14
Q1 2024 Unchanged 600,000 0 (0.0%) 1.66% $33,654,000 2024-05-15
Q4 2023 Unchanged 600,000 0 (0.0%) 1.8% $36,102,000 2024-02-14
Q3 2023 Unchanged 600,000 0 (0.0%) 2.15% $40,302,000 2023-11-14
Q2 2023 New 600,000 +600,000 (0.0%) 1.92% $41,418,000 2023-08-14

Who else reported the position

215 managers reported LEGEND BIOTECH CORP for Q3 2023.

Managers reporting LEGEND BIOTECH CORP in Q3 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Reduced 15,905,448 -1,140,050 0.09% $1,068,368,938 14 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 9,693,368 +662,044 0.1% $651,105,000 6 qtrs
HHLR ADVISORS LTD Unchanged 6,436,533 0 9.65% $432,341,922 14 qtrs
RA CAPITAL MANAGEMENT L P Unchanged 6,264,707 0 8.28% $420,800,369 5 qtrs
BlackRock Inc Reduced 4,621,034 -122,560 < 0.01% $310,394,854 14 qtrs
Capital World Investors Reduced 2,387,832 -143 0.03% $160,390,675 14 qtrs
Paradigm Biocapital Advisors LP Added 2,025,480 +219,763 9.23% $136,051,492 8 qtrs
Polar Capital Holdings Plc Unchanged 1,872,118 0 0.93% $125,750,166 7 qtrs
MASSACHUSETTS FINANCIAL SERVICES CO MA Added 1,867,032 +212,327 0.04% $125,408,539 4 qtrs
Capital International Investors Reduced 1,832,803 -29,206 0.03% $123,109,378 14 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2023
Filed
November 14, 2023
Filing type
13F-HR
Position type
Sponsored ADS

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.